Medpace Holdings, Inc. Deferred Income Tax Assets, Net
Medpace Holdings, Inc. (MEDP) had Deferred Income Tax Assets, Net of $3.23 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-07-23
- 2026-06-30: Deferred Income Tax Assets, Net $3.23M.
- 2026-03-31: Deferred Income Tax Assets, Net $3.22M.
- 2025-12-31: Deferred Income Tax Assets, Net $19.22M.
- 2025-09-30: Deferred Income Tax Assets, Net $37.19M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $3.23M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $3.22M 10-Q · filed 2026-04-23 |
| 2025-12-31 | $19.22M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $37.19M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $65.79M 10-Q · filed 2025-07-22 |
| 2025-03-31 | $99.69M 10-Q · filed 2025-04-22 |
| 2024-12-31 | $100.36M 10-K · filed 2026-02-10 |
| 2024-09-30 | $76.68M 10-Q · filed 2024-10-22 |
| 2024-06-30 | $75.20M 10-Q · filed 2024-07-23 |
| 2024-03-31 | $75.23M 10-Q · filed 2024-04-23 |
| 2023-12-31 | $74.44M 10-K · filed 2025-02-11 |
| 2023-09-30 | $59.34M 10-Q · filed 2023-10-24 |
| 2023-06-30 | $51.77M 10-Q · filed 2023-07-25 |
| 2023-03-31 | $49.16M 10-Q · filed 2023-04-25 |
| 2022-12-31 | $48.08M 10-K · filed 2024-02-13 |
| 2022-09-30 | $27.02M 10-Q · filed 2022-10-25 |
| 2022-06-30 | $26.44M 10-Q · filed 2022-07-26 |
| 2022-03-31 | $25.81M 10-Q · filed 2022-04-26 |
| 2021-12-31 | $25.13M 10-K · filed 2023-02-14 |
| 2021-09-30 | $1.27M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $540.00K 10-Q · filed 2021-07-27 |
| 2021-03-31 | $556.00K 10-Q · filed 2021-04-27 |
| 2020-12-31 | $536.00K 10-K · filed 2022-02-15 |
| 2020-09-30 | $477.00K 10-Q · filed 2020-10-27 |
| 2020-06-30 | $469.00K 10-Q · filed 2020-07-28 |
| 2019-12-31 | $376.00K 10-K · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |